Mitral valve regurgitation surgery: Difference between revisions

Jump to navigation Jump to search
Mohammed Sbeih (talk | contribs)
Mohammed Sbeih (talk | contribs)
Line 49: Line 49:
===Severe LV Dysfunction with a Dilated Ventricle===
===Severe LV Dysfunction with a Dilated Ventricle===
The patient with severe LV dysfunction (an LVEF < 30% and/or a left ventricular end-systolic dimension greater than 55 mm poses a higher risk but may undergo surgery if chordal preservation is likely.
The patient with severe LV dysfunction (an LVEF < 30% and/or a left ventricular end-systolic dimension greater than 55 mm poses a higher risk but may undergo surgery if chordal preservation is likely.
==Overview==
Mitral valve surgery is indicated when the [[mitral regurgitation]] is severe or when the patient is symptomatic.
Valve repair or replacement are the two types of surgeries available to treat these conditions. Decision between valve repair or valve replacement is made based on the type and severity of damage to [[mitral valve]].
==Indications==
'''[[Mitral valve repair]]''' is recommended in following:
*Limited damage to certain areas of the mitral valve leaflets or [[chordae tendineae]]<ref name="pmid12830055">{{cite journal| author=Gillinov AM, Faber C, Houghtaling PL, Blackstone EH, Lam BK, Diaz R et al.| title=Repair versus replacement for degenerative mitral valve disease with coexisting ischemic heart disease. | journal=J Thorac Cardiovasc Surg | year= 2003 | volume= 125 | issue= 6 | pages= 1350-62 | pmid=12830055 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12830055  }} </ref>
*Limited calcification of the leaflets or annulus
*[[Mitral valve prolapse|Prolapse]] of less than one-third of either leaflet
*Pure annular dilatation
*Valvular perforations
*Incomplete [[papillary muscle rupture]]
'''[[Mitral valve replacement]]''' is recommended in following:
*Extensive calcification or degeneration of a leaflet or annulus
*[[Mitral valve prolapse|Prolapse]] of more than one-third of the leaflet tissue
*Extensive chordal fusion, calcification, or [[papillary muscle rupture]]
*Extensive damage of mitral valve secondary to [[endocarditis]]
==Clinical trial data==
*Multiple studies have shown that there are better outcomes in terms of left ventricular function and survival with mitral valve repair compared to valve replacement.<ref name="pmid3769948">{{cite journal| author=Krayenbuehl HP| title=Surgery for mitral regurgitation. Repair versus valve replacement. | journal=Eur Heart J | year= 1986 | volume= 7 | issue= 8 | pages= 638-43 | pmid=3769948 | doi= | pmc= | url= }} </ref><ref name="pmid7850937">{{cite journal| author=Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL| title=Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. | journal=Circulation | year= 1995 | volume= 91 | issue= 4 | pages= 1022-8 | pmid=7850937 | doi= | pmc= | url= }} </ref><ref name="pmid10612761">{{cite journal| author=Yau TM, El-Ghoneimi YA, Armstrong S, Ivanov J, David TE| title=Mitral valve repair and replacement for rheumatic disease. | journal=J Thorac Cardiovasc Surg | year= 2000 | volume= 119 | issue= 1 | pages= 53-60 | pmid=10612761 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10612761  }} </ref><ref name="pmid9918527">{{cite journal| author=Tribouilloy CM, Enriquez-Sarano M, Schaff HV, Orszulak TA, Bailey KR, Tajik AJ et al.| title=Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. | journal=Circulation | year= 1999 | volume= 99 | issue= 3 | pages= 400-5 | pmid=9918527 | doi= | pmc= | url= }} </ref>
*In a 6 year follow-up study<ref name="pmid16293530">{{cite journal| author=Kouris N, Ikonomidis I, Kontogianni D, Smith P, Nihoyannopoulos P| title=Mitral valve repair versus replacement for isolated non-ischemic mitral regurgitation in patients with preoperative left ventricular dysfunction. A long-term follow-up echocardiography study. | journal=Eur J Echocardiogr | year= 2005 | volume= 6 | issue= 6 | pages= 435-42 | pmid=16293530 | doi=10.1016/j.euje.2005.01.003 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16293530  }} </ref> of 45 patients with isolated non-ischemic [[mitral regurgitation]] and [[EF]] ≤50%, who underwent either valve repair(27 patients) or replacement(18 patients) following results were observed:
::*5 patients and 6 patients died in repair group and replacement group respectively.
::*2 patients underwent valve replacement due to failure of valve repair while 1 patient in valve replacement group underwent re-operation due to [[prosthetic valve endocarditis]].
::*Incidence of [[atrial fibrillation]] was similar between both groups.
::*Left ventricular end diastolic dimension(LVEDD), [[velocity time integral]] and [[ejection fraction]](EF) improved with valve repair while LVEDD and EF worsened in valve replacement patients.
*In another study, lower operative mortality (2.6% vs 10.3%), greater increase in left ventricular [[EF]] and higher 10 years survival rate (68% vs 52%) were observed among patients who underwent valve repair compared to valve replacement.<ref name="pmid9323067">{{cite journal| author=Ling LH, Enriquez-Sarano M, Seward JB, Orszulak TA, Schaff HV, Bailey KR et al.| title=Early surgery in patients with mitral regurgitation due to flail leaflets: a long-term outcome study. | journal=Circulation | year= 1997 | volume= 96 | issue= 6 | pages= 1819-25 | pmid=9323067 | doi= | pmc= | url= }} </ref>
*A survival benefit with valve repair may not be seen in high risk patients with [[ischemic MR]].<ref name="pmid11726887">{{cite journal| author=Gillinov AM, Wierup PN, Blackstone EH, Bishay ES, Cosgrove DM, White J et al.| title=Is repair preferable to replacement for ischemic mitral regurgitation? | journal=J Thorac Cardiovasc Surg | year= 2001 | volume= 122 | issue= 6 | pages= 1125-41 | pmid=11726887 | doi=10.1067/mtc.2001.116557 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11726887  }} </ref><ref name="pmid11726886">{{cite journal| author=Grossi EA, Goldberg JD, LaPietra A, Ye X, Zakow P, Sussman M et al.| title=Ischemic mitral valve reconstruction and replacement: comparison of long-term survival and complications. | journal=J Thorac Cardiovasc Surg | year= 2001 | volume= 122 | issue= 6 | pages= 1107-24 | pmid=11726886 | doi=10.1067/mtc.2001.116945 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11726886  }} </ref>
*Long term rates of re-operation appear to be similar in both valve repair and replacement.<ref name="pmid16928491">{{cite journal| author=Suri RM, Schaff HV, Dearani JA, Sundt TM, Daly RC, Mullany CJ et al.| title=Survival advantage and improved durability of mitral repair for leaflet prolapse subsets in the current era. | journal=Ann Thorac Surg | year= 2006 | volume= 82 | issue= 3 | pages= 819-26 | pmid=16928491 | doi=10.1016/j.athoracsur.2006.03.091 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16928491  }} </ref> However, among patients who underwent mitral valve surgeries between 1984 and 1997, 10 year rates of re-operation was shown to be lower with valve repair.<ref name="pmid12835220">{{cite journal| author=Thourani VH, Weintraub WS, Guyton RA, Jones EL, Williams WH, Elkabbani S et al.| title=Outcomes and long-term survival for patients undergoing mitral valve repair versus replacement: effect of age and concomitant coronary artery bypass grafting. | journal=Circulation | year= 2003 | volume= 108 | issue= 3 | pages= 298-304 | pmid=12835220 | doi=10.1161/01.CIR.0000079169.15862.13 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12835220  }} </ref>
==Summary==
'''Advantages of [[Mitral valve repair]]:'''
#Improves left ventricular [[EF]] and function.
#Preserves native heart valve.
#Avoids long term use of [[anticoagulants]].
#Lower risk for [[endocarditis]].
#Has good overall outcome with good survival rates.
Based on above, '''ACC/AHA 2008 guidelines'''<ref name="pmid18848134">{{cite journal| author=Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD et al.| title=2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. | journal=J Am Coll Cardiol | year= 2008 | volume= 52 | issue= 13 | pages= e1-142 | pmid=18848134 | doi=10.1016/j.jacc.2008.05.007 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18848134  }} </ref> recommend [[mitral valve repair]] rather than [[mitral valve replacement]] if the anatomy is appropriate, including patients with [[rheumatic]] mitral valve disease<ref name="pmid10612761">{{cite journal| author=Yau TM, El-Ghoneimi YA, Armstrong S, Ivanov J, David TE| title=Mitral valve repair and replacement for rheumatic disease. | journal=J Thorac Cardiovasc Surg | year= 2000 | volume= 119 | issue= 1 | pages= 53-60 | pmid=10612761 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10612761  }} </ref> and mitral valve prolapse<ref name="pmid11568020">{{cite journal| author=Mohty D, Orszulak TA, Schaff HV, Avierinos JF, Tajik JA, Enriquez-Sarano M| title=Very long-term survival and durability of mitral valve repair for mitral valve prolapse. | journal=Circulation | year= 2001 | volume= 104 | issue= 12 Suppl 1 | pages= I1-I7 | pmid=11568020 | doi= | pmc= | url= }} </ref> (Grade 1C). The procedure should be performed at experienced surgical centers.


==References==
==References==

Revision as of 17:27, 25 August 2011

WikiDoc Resources for Mitral valve regurgitation surgery

Articles

Most recent articles on Mitral valve regurgitation surgery

Most cited articles on Mitral valve regurgitation surgery

Review articles on Mitral valve regurgitation surgery

Articles on Mitral valve regurgitation surgery in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Mitral valve regurgitation surgery

Images of Mitral valve regurgitation surgery

Photos of Mitral valve regurgitation surgery

Podcasts & MP3s on Mitral valve regurgitation surgery

Videos on Mitral valve regurgitation surgery

Evidence Based Medicine

Cochrane Collaboration on Mitral valve regurgitation surgery

Bandolier on Mitral valve regurgitation surgery

TRIP on Mitral valve regurgitation surgery

Clinical Trials

Ongoing Trials on Mitral valve regurgitation surgery at Clinical Trials.gov

Trial results on Mitral valve regurgitation surgery

Clinical Trials on Mitral valve regurgitation surgery at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mitral valve regurgitation surgery

NICE Guidance on Mitral valve regurgitation surgery

NHS PRODIGY Guidance

FDA on Mitral valve regurgitation surgery

CDC on Mitral valve regurgitation surgery

Books

Books on Mitral valve regurgitation surgery

News

Mitral valve regurgitation surgery in the news

Be alerted to news on Mitral valve regurgitation surgery

News trends on Mitral valve regurgitation surgery

Commentary

Blogs on Mitral valve regurgitation surgery

Definitions

Definitions of Mitral valve regurgitation surgery

Patient Resources / Community

Patient resources on Mitral valve regurgitation surgery

Discussion groups on Mitral valve regurgitation surgery

Patient Handouts on Mitral valve regurgitation surgery

Directions to Hospitals Treating Mitral valve regurgitation surgery

Risk calculators and risk factors for Mitral valve regurgitation surgery

Healthcare Provider Resources

Symptoms of Mitral valve regurgitation surgery

Causes & Risk Factors for Mitral valve regurgitation surgery

Diagnostic studies for Mitral valve regurgitation surgery

Treatment of Mitral valve regurgitation surgery

Continuing Medical Education (CME)

CME Programs on Mitral valve regurgitation surgery

International

Mitral valve regurgitation surgery en Espanol

Mitral valve regurgitation surgery en Francais

Business

Mitral valve regurgitation surgery in the Marketplace

Patents on Mitral valve regurgitation surgery

Experimental / Informatics

List of terms related to Mitral valve regurgitation surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Indications for Surgery in Chronic Mitral Regurgitation

Indications for surgery for chronic mitral regurgitation include signs of left ventricular dysfunction. These include a left ventricular ejection fraction (LVEF) of less than 60% and a left ventricular end systolic dimension (LVESD) of greater than 45 mm.

Indications for surgery for chronic mitral regurgitation[1]
Symptoms LV EF LVESD
NYHA II - IV> 60 percent< 45 mm
Asymptomatic or symptomatic50 - 60 percent≥ 45 mm
Asymptomatic or symptomatic< 50 percent or ≥ 45 mm
Pulmonary artery systolic pressure ≥ 50 mmHg









Factors influencing the timing of surgery for MR include symptoms, LV EF, LV end-systolic dimension, atrial fibrillation, and pulmonary hypertension. In most situations, MV repair is the operation of choice for those patients with suitable MV anatomy.

Specific Patient Populations

Severe MR and Any Symptoms

An operation is indicated for most patients with severe MR and any symptoms.

Severe MR and No Symptoms

There is controversy regarding the timing of surgery in the asymptomatic patient with severe MR and normal LV function. If MV repair can be performed with a high degree of success and the operative risk is low, it is reasonable to proceed with surgery to prevent irreversible LV dysfunction from occurring. However, this “early” operation should only be performed at centers in which there is a high likelihood of successful MV repair because of their demonstrated expertise in this area.

Asymptomatic Patients with Mild to Moderate LV Dysfunction

An operation is also indicated in asymptomatic patients who demonstrate mild to moderate LV dysfunction (an LVEF of 30% to 60%) and a left ventricular end-systolic dimension 40 to 55 mm).

Severe LV Dysfunction with a Dilated Ventricle

The patient with severe LV dysfunction (an LVEF < 30% and/or a left ventricular end-systolic dimension greater than 55 mm poses a higher risk but may undergo surgery if chordal preservation is likely.

Overview

Mitral valve surgery is indicated when the mitral regurgitation is severe or when the patient is symptomatic. Valve repair or replacement are the two types of surgeries available to treat these conditions. Decision between valve repair or valve replacement is made based on the type and severity of damage to mitral valve.


Indications

Mitral valve repair is recommended in following:

  • Limited damage to certain areas of the mitral valve leaflets or chordae tendineae[2]
  • Limited calcification of the leaflets or annulus
  • Prolapse of less than one-third of either leaflet
  • Pure annular dilatation
  • Valvular perforations
  • Incomplete papillary muscle rupture


Mitral valve replacement is recommended in following:

  • Extensive calcification or degeneration of a leaflet or annulus
  • Prolapse of more than one-third of the leaflet tissue
  • Extensive chordal fusion, calcification, or papillary muscle rupture
  • Extensive damage of mitral valve secondary to endocarditis


Clinical trial data

  • Multiple studies have shown that there are better outcomes in terms of left ventricular function and survival with mitral valve repair compared to valve replacement.[3][4][5][6]
  • In a 6 year follow-up study[7] of 45 patients with isolated non-ischemic mitral regurgitation and EF ≤50%, who underwent either valve repair(27 patients) or replacement(18 patients) following results were observed:
  • 5 patients and 6 patients died in repair group and replacement group respectively.
  • 2 patients underwent valve replacement due to failure of valve repair while 1 patient in valve replacement group underwent re-operation due to prosthetic valve endocarditis.
  • Incidence of atrial fibrillation was similar between both groups.
  • Left ventricular end diastolic dimension(LVEDD), velocity time integral and ejection fraction(EF) improved with valve repair while LVEDD and EF worsened in valve replacement patients.
  • In another study, lower operative mortality (2.6% vs 10.3%), greater increase in left ventricular EF and higher 10 years survival rate (68% vs 52%) were observed among patients who underwent valve repair compared to valve replacement.[8]
  • A survival benefit with valve repair may not be seen in high risk patients with ischemic MR.[9][10]
  • Long term rates of re-operation appear to be similar in both valve repair and replacement.[11] However, among patients who underwent mitral valve surgeries between 1984 and 1997, 10 year rates of re-operation was shown to be lower with valve repair.[12]


Summary

Advantages of Mitral valve repair:

  1. Improves left ventricular EF and function.
  2. Preserves native heart valve.
  3. Avoids long term use of anticoagulants.
  4. Lower risk for endocarditis.
  5. Has good overall outcome with good survival rates.


Based on above, ACC/AHA 2008 guidelines[13] recommend mitral valve repair rather than mitral valve replacement if the anatomy is appropriate, including patients with rheumatic mitral valve disease[5] and mitral valve prolapse[14] (Grade 1C). The procedure should be performed at experienced surgical centers.

References

  1. "ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease)". Journal of the American College of Cardiology. 32 (5): 1486–588. 1998. PMID 9809971. Retrieved 2011-03-16. Unknown parameter |month= ignored (help)
  2. Gillinov AM, Faber C, Houghtaling PL, Blackstone EH, Lam BK, Diaz R; et al. (2003). "Repair versus replacement for degenerative mitral valve disease with coexisting ischemic heart disease". J Thorac Cardiovasc Surg. 125 (6): 1350–62. PMID 12830055.
  3. Krayenbuehl HP (1986). "Surgery for mitral regurgitation. Repair versus valve replacement". Eur Heart J. 7 (8): 638–43. PMID 3769948.
  4. Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL (1995). "Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis". Circulation. 91 (4): 1022–8. PMID 7850937.
  5. 5.0 5.1 Yau TM, El-Ghoneimi YA, Armstrong S, Ivanov J, David TE (2000). "Mitral valve repair and replacement for rheumatic disease". J Thorac Cardiovasc Surg. 119 (1): 53–60. PMID 10612761.
  6. Tribouilloy CM, Enriquez-Sarano M, Schaff HV, Orszulak TA, Bailey KR, Tajik AJ; et al. (1999). "Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications". Circulation. 99 (3): 400–5. PMID 9918527.
  7. Kouris N, Ikonomidis I, Kontogianni D, Smith P, Nihoyannopoulos P (2005). "Mitral valve repair versus replacement for isolated non-ischemic mitral regurgitation in patients with preoperative left ventricular dysfunction. A long-term follow-up echocardiography study". Eur J Echocardiogr. 6 (6): 435–42. doi:10.1016/j.euje.2005.01.003. PMID 16293530.
  8. Ling LH, Enriquez-Sarano M, Seward JB, Orszulak TA, Schaff HV, Bailey KR; et al. (1997). "Early surgery in patients with mitral regurgitation due to flail leaflets: a long-term outcome study". Circulation. 96 (6): 1819–25. PMID 9323067.
  9. Gillinov AM, Wierup PN, Blackstone EH, Bishay ES, Cosgrove DM, White J; et al. (2001). "Is repair preferable to replacement for ischemic mitral regurgitation?". J Thorac Cardiovasc Surg. 122 (6): 1125–41. doi:10.1067/mtc.2001.116557. PMID 11726887.
  10. Grossi EA, Goldberg JD, LaPietra A, Ye X, Zakow P, Sussman M; et al. (2001). "Ischemic mitral valve reconstruction and replacement: comparison of long-term survival and complications". J Thorac Cardiovasc Surg. 122 (6): 1107–24. doi:10.1067/mtc.2001.116945. PMID 11726886.
  11. Suri RM, Schaff HV, Dearani JA, Sundt TM, Daly RC, Mullany CJ; et al. (2006). "Survival advantage and improved durability of mitral repair for leaflet prolapse subsets in the current era". Ann Thorac Surg. 82 (3): 819–26. doi:10.1016/j.athoracsur.2006.03.091. PMID 16928491.
  12. Thourani VH, Weintraub WS, Guyton RA, Jones EL, Williams WH, Elkabbani S; et al. (2003). "Outcomes and long-term survival for patients undergoing mitral valve repair versus replacement: effect of age and concomitant coronary artery bypass grafting". Circulation. 108 (3): 298–304. doi:10.1161/01.CIR.0000079169.15862.13. PMID 12835220.
  13. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD; et al. (2008). "2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". J Am Coll Cardiol. 52 (13): e1–142. doi:10.1016/j.jacc.2008.05.007. PMID 18848134.
  14. Mohty D, Orszulak TA, Schaff HV, Avierinos JF, Tajik JA, Enriquez-Sarano M (2001). "Very long-term survival and durability of mitral valve repair for mitral valve prolapse". Circulation. 104 (12 Suppl 1): I1–I7. PMID 11568020.

Template:WH Template:WS